Navigation Links
ARB in Medical News

HLTH Corporation Announces Second Quarter Financial Results

...ed Financial Statements - an amendment of arb No. 51" and (ii) the reclassification of WebMD's ...ed Financial Statements - an amendment of arb No. 51" and (ii) the reclassification of ...onsolidated Financial Statements - an amendment of arb No. 51" and (ii) the reclassification of ...

BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results

...onsolidated Financial Statements - An Amendment of arb No. 51"; and FASB Staff Position EITF 03-6-1 "Dete...nsolidated Financial Statements -- An Amendment of arb No. 51"; and FASB Staff Position EITF 03-6-1 "Dete...nsolidated Financial Statements -- An Amendment of arb No. 51"; and FASB Staff Position EITF 03-6-1 "Dete...

Quest Diagnostics Reports Strong Performance in Second Quarter 2009

...he Company adopted Statement of Financial Accounting Standard No. 160, "Noncontrolling Interests in Consolidated Financial Statements, an Amendment of arb No. 51" ("SFAS 160"), the provisions of which, among other things, require that minority interests be renamed "Net income attributable to noncontrolli...

AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure

...rrow. Together the two medicines relax the blood vessels so that blood can flow more easily. Benicar (olmesartan medoxomil), Daiichi Sankyo's flagship arb product, is the fastest growing medication in the fastest growing class of blood pressure-lowering drugs.(9) The U.S. Food and Drug Administrati...

All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke

...while beta blockers reduced the risk by about 22 percent, and ACE-inhibitors reduced the risk by about 16 percent. Starting treatment with a diuretic, arb or calcium channel blocker did not produce significantly different results, the researchers added. As with the other analyses, there was no signifi...

HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009

...09, we adopted Financial Accounting Standards Board Statement No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of arb No. 51 . As a result, we have reclassified our noncontrolling interests (formerly known as "minority interests") as a component of equity and now repo...

BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results

...onsolidated Financial Statements - An Amendment of arb No. 51"; and FASB Staff Position EITF 03-6-1 "Dete...onsolidated Financial Statements - An Amendment of arb No. 51"; and FASB Staff Position EITF 03-6-1 "...onsolidated Financial Statements - An Amendment of arb No. 51"; and FASB Staff Position EITF 03-6-1 "...

Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009

...he Company adopted Statement of Financial Accounting Standard No. 160, "Noncontrolling Interests in Consolidated Financial Statements, an Amendment of arb No. 51" ("SFAS 160"), the provisions of which, among others, requires that minority interests be renamed "Net income attributable to noncontrolling in...

Viagra May Shield Heart From Blood Pressure Damage

...ibitors and possibly sildenafil, for people with heart failure who will benefit most," Kass said. Doctors currently use so-called ACE inhibitor and arb inhibitor drugs to block Gq signaling. These drugs are the most common treatment for heart failure, which afflicts more than 5 million Americans each ...

Joint Commission Report Shows Gains in Safety, Quality

...percent compliance ACE (angiotensin converting enzyme) inhibitor or arb (angiotensin receptor blocker) prescribed at discharge for heart failure pa...ercent of hospitals achieved 90 percent compliance ACE inhibitor or arb prescribed at discharge for heart attack patients - only 68.8 percent of ho...

More>>

ARB in Medical Technology

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

...n important vehicle for increasing the use of these medications among people with diabetes. The American Diabetes Association recommends ACE-I or arb in diabetic patients with certain clinical conditions such as nephropathy or hypertension. Unfortunately, these agents are not frequently prescribed ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... to achieve a target BP of <130/80. Patients requiring treatment with an arb or ACEi were withdrawn from the study. About the ROADMAP One-Year Res... to an elevation in blood pressure. Olmesartan medoxomil is a member of the arb class of antihypertensive medications that help lower blood pressure by blo...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood pressure. BENICAR is a member of the arb class of antihypertensive medications that help lower blood pressure by blocking the angiotensin II receptor on the blood vessels and antagonizing the...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

...rrow. Together the two medicines relax the blood vessels so that blood can flow more easily. Benicar (olmesartan medoxomil), Daiichi Sankyo's flagship arb product, is the fastest growing medication in the fastest growing class of blood pressure-lowering drugs.(13) The U.S. Food and Drug Administrati...

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

... Landmark arb trial investigated Micardis(R) (telmisartan) against placebo in reducing...ailure, and resulted in fewer discontinuations. Telmisartan is now the only arb to have demonstrated cardio and vascular risk reduction benefits beyond low...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

... a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood pressure. BENICAR is a member of the arb class of antihypertensive medications that help lower blood pressure by blocking the angiotensin II receptor on the blood vessels and antagonizing the...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

... a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood pressure. BENICAR is a member of the arb class of antihypertensive medications that help lower blood pressure by blocking the angiotensin II receptor on the blood vessels and antagonizing the...

Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population

...as 1.01, with a 95 percent CI of 0.94 - 1.09. Telmisartan is now the only arb to have demonstrated cardio and vascular risk reduction benefits beyond low...nge of cardiovascular diseases. The study compared the effectiveness of the arb telmisartan to the ACE inhibitor ramipril in reducing the combined risk of ...

Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference

...84 group and -6.2 ml/min/1.73m2 in the placebo group (p=0.077). In an exploratory analysis, subjects were stratified according to dose of ACEi and/or arb received (as a percentage of the maximum FDA recommended dose). The benefit of XL784 compared to placebo increased with increasing dose of ACEi and/or...

Tekturna, First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan

...Novartis remains at the forefront of cardiovascular medicine through development of innovative products like DIOVAN, the most-prescribed member of the arb class (angiotensin receptor blocker) in the world today. DIOVAN is available for the treatment of high blood pressure in more than 100 countries, for ...

More>>

Other Tags
(Date:7/25/2014)... The new report “Carbohydrase Market by Applications (Food ... Type (Amylases, Cellulases, and Others), Source (Microorganisms, Animals, ... Forecasts to 2019", by MarketsandMarkets, identifies the driving ... with analysis of trends, opportunities, winning imperatives, and ... forecasted on the basis of major regions such ...
(Date:7/25/2014)... 25, 2014 In today’s technological era, ... and supporting devices. This benefits the organization in various ... cyber attacks which can destroy the confidential information and ... Risk and Compliance (EGRC) manage and protect the enterprise ... can cause loss in dollars to the comp may. ...
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 ... injury law firm with over 25 years of ... stemming from dangerous prescription drugs, announces the launch ... offer information to those who believe they have ... , The site offers valuable information about the ...
(Date:7/25/2014)... The European liquid chromatography reagents report defines ... and forecast of revenue. The liquid chromatography reagents market ... 2013, and is estimated to grow to around $1581.8 ... from 2013 to 2018. , Browse through the TOC ... an idea of the in-depth analysis provided. This also ...
(Date:7/25/2014)... the vast majority of adults finish all of the food ... new study. This is true for adults from ... Cornell University revealed. They noted their findings could help ... make better choices. "If you put it on your ... director of the Cornell Food and Brand Lab, said in ...
Breaking Medicine News(10 mins):Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 4Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:North America Enterprise Governance, Risk, and Compliance Market is Expected to Reach $3,972.6 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Rottenstein Law Group LLP Announces Launch of Xarelto Injury Website 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Most Adults Are Members of 'Clean Plate Club' 2
(Date:7/24/2014)... 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") ... active control Phase 3 study of Zerenex (ferric citrate), ... the treatment of hyperphosphatemia in patients with end-stage renal ... and iRon delivery with FErric CiTrate in EsrD) was ... American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... numbers have decreased by 45% on average over a ... reports a study on the impact of humans on ... enormous benefits invertebrates such as insects, spiders, crustaceans, slugs ... and pest control for crops, decomposition for nutrient cycling, ... in Science and led by UCL, Stanford ...
(Date:7/24/2014)... the product of 3.5 billion years of evolutionary trial ... life. But it may be reaching a tipping point. ... analysis of data published in Science , an ... decline of animals is contributing to what appears to ... biological extinction event. , Since 1500, more than 320 ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3
Other Contents